Evidence map›Paper›PMID 31942009›Full record

ArticleScientific reports2020

Encapsulation boosts islet-cell signature in differentiating human induced pluripotent stem cells via integrin signalling.

Thomas Aga Legøy, Heidrun Vethe, Shadab Abadpour, Berit L Strand, Hanne Scholz, Joao A Paulo, Helge Ræder, Luiza Ghila, Simona Chera

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Advanced therapy to cure diabetes: mission impossible is now possible?Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Frontiers in cell and developmental biology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Thomas Aga LegøyDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Heidrun VetheDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Shadab AbadpourHybrid Technology Hub-Centre of Excellence, Faculty of Medicine, University of Oslo, Oslo, Norway.
Berit L StrandNOBIPOL, Department of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim, Norway.
Hanne ScholzHybrid Technology Hub-Centre of Excellence, Faculty of Medicine, University of Oslo, Oslo, Norway.
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Helge RæderDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Luiza GhilaDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-7173-6312
Simona CheraDepartment of Clinical Science, University of Bergen, Bergen, Norway. Simona.Chera@uib.no.ORCID http://orcid.org/0000-0001-6310-3486
University of Bergen · NOOslo University Hospital · NOHarvard University · USHaukeland University Hospital · NONorwegian University of Science and Technology · NO

Funding

Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

Cell replacement therapies hold great therapeutic potential. Nevertheless, our knowledge of the mechanisms governing the developmental processes is limited, impeding the quality of differentiation protocols. Generating insulin-expressing cells in vitro is no exception, with the guided series of differentiation events producing heterogeneous cell populations that display mixed pancreatic islet phenotypes and immaturity. The achievement of terminal differentiation ultimately requires the in vivo transplantation of, usually, encapsulated cells. Here we show the impact of cell confinement on the pancreatic islet signature during the guided differentiation of alginate encapsulated human induced pluripotent stem cells (hiPSCs). Our results show that encapsulation improves differentiation by significantly reshaping the proteome landscape of the cells towards an islet-like signature. Pathway analysis is suggestive of integrins transducing the encapsulation effect into intracellular signalling cascades promoting differentiation. These analyses provide a molecular framework for understanding the confinement effects on hiPSCs differentiation while confirming its importance for this process.

Indexed as

Cell DifferentiationAlginatesBiomarkersCell ProliferationCells, CulturedCell SurvivalGene Expression ProfilingHumansInduced Pluripotent Stem CellsInsulinIntegrinsIslets of LangerhansPhenotypeSignal TransductionAlginatesBiomarkersInsulinIntegrins

Identifiers

PMID31942009
PMCPMC6962451
OpenAlexW2999764249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.